The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pal'tseva E.M.

Laboratoriia élektronnoĭ mikroskopii i immunogistokhimii Tsentralizovannogo patologoanatomicheskogo otdeleniia GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdravsotsrazvitiia Rossii

Samofalova O.Iu.

Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo RAMN, Moskva

Gorbacheva Iu.V.

Laboratoriia élektronnoĭ mikroskopii i immunogistokhimii Tsentralizovannogo patologoanatomicheskogo otdeleniia GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdravsotsrazvitiia Rossii

Tsar'kov P.V.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Expression of some biomarkers in primary colon adenocarcinomas and their lymph node metastases

Authors:

Pal'tseva E.M., Samofalova O.Iu., Gorbacheva Iu.V., Tsar'kov P.V.

More about the authors

Read: 3911 times


To cite this article:

Pal'tseva EM, Samofalova OIu, Gorbacheva IuV, Tsar'kov PV. Expression of some biomarkers in primary colon adenocarcinomas and their lymph node metastases. Russian Journal of Archive of Pathology. 2012;74(4):12‑20. (In Russ.)

Recommended articles:
Quality control of immu­nohistochemical studies: compulsory duty or urgent need?. Russian Journal of Archive of Pathology. 2025;(2):43-52
Soli­tary fibrous tumor of the kidney. Russian Journal of Archive of Pathology. 2025;(3):77-81
Prognostically unfa­vorable types of breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(6):78-82

References:

  1. Nemtsova M.V., Pal'tseva E.M., Babayan A.Yu. i dr. Molekulyarno-geneticheskii analiz klonal'noi vnutriopukholevoi geterogennosti v kolorektal'nykh kartsinomakh. Molekul biol 2008; 42:6: 1040-1047.
  2. Buob D., Fauvel H., Buisine M.P. et al. The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection. Dig Dis Sci 2012; 57: 5: 1271-1280. http://www.springerlink.com/content/?k=Buob+D.%2c+Fauvel+H.%2c+Buisine+M.P.
  3. Choi H.N., Kim K.R., Lee J.H. et al. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Oncol Rep 2009; 21: 1: 57-63.
  4. Czyzewska J., Guzińska-Ustymowicz K., Ustymowicz M. et al. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastases. Folia Histochem Cytobiol 2010; 48: 1: 37-45.
  5. Dassoulas K., Gazouli M., Rizos S. et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009; 48: 6: 563-569.
  6. Deng Y., Kurland B.F., Wang J. et al. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Am J Clin Oncol 2009; 32: 3: 245-252.
  7. Elzagheid A., Ålgars A., Bendardaf R. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol 2006; 12: 27: 4304-4309.
  8. Graziano F., Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003; 14: 1026-1038.
  9. Gulubova M., Vlaykova T. Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem 2006; 108: 1: 25-35.
  10. Han S.A., Chun H., Park C.M. et al. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Clin Oncol (R Coll Radiol) 2006; 18: 10: 761-767.
  11. László L. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer. Magy Onkol 2010; 54: 383-394.
  12. Libra M., Navolanic P.M., Talamini R. et al. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy. BMC Cancer 2004; 4: 11-16.
  13. Malik F.A., Sanders A.J., Jiang W.G. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis. Histol Histopathol 2009; 24: 4: 519-530.
  14. Molinary F., Martin V., Saletti P. et al. Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Brit J Cancer 2009; 100: 1087-1094.
  15. Öhrling K., Edler D., Hallström M. et al. Detection of thymidylate synthase in lymph node metastases of colorectal cancer can improve the prognostic information. J Clin Oncol 2005; 23: 24: 5628-5634.
  16. Pohl M., Werner N., Munding J. et al. Biomarkers of anti-angiogenic therapy in metastatic colorectal ancer (mCRC): original data and review of the literature. J Gastroenterol 2011; 49: 10: 1398-1406.
  17. van Obberghen-Schilling E., Tucker R.P., Saupe F. et al. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 2011; 55: 4-5: 511-525.
  18. Wei Q., Shui Y., Zheng S. et al. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy. Oncol Rep 2011; 25: 3-11.
  19. Wu D.-H., Liu L., Chen L.-H., Ding Y.-Q. KAI1 gene expression in colonic carcinoma and its clinical significances. World J Gastroenterol 2004; 10: 15: 2245-2249.
  20. Yamada H., Ichikawa W., Uetake H. et al. Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites. Clin Colorectal Cancer 2001; 1: 3: 169-173.
  21. Yang J., Liu F.X., Yan X.C. et al. Role of tumor metastasis suppressor gene KAI1 in development of colorectal cancer. Ai Zheng 2003; 22: 5: 533-536.
  22. Yarom N., Marginean C., Moyana T. et al. EGFR expression variance in paired colorectal cancer primary and metastatic tumors. Cancer Biol Ther 2010; 10: 5: 416-421.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.